Post Profile






Breathe Deeply: Safety Concerns Over Spiriva

Several months after concerns were raised about the safety of the blockbuster Spiriva inhaler that is used to treat chronic obstructive pulmonary disease, a previously unpublished epidemiological study has surfaced. And the data, which has been published in BMJ Open, indicates the medication is associated with an increased risk of angina, heart attacks and stroke [...]
read more

share

Related Posts


Is Boehringer Providing Proper Informed Consent?

Medical / Pharmaceutical : Pharmalot (4 years ago)

Earlier today, we wrote how a new meta-analysis in BMJ found that Spiriva, a medication used to treat chronic obstructive pulmonary disease, may raise the risk of an early death by 52 percent. The results have generated considerable...

Pfizer-Boehringer’s Spiriva May Raise Death Risk, Analysis of Studies Says - Bloomberg

Medical / Pharmaceutical : PharmaGossip (4 years ago)

Boehringer Ingelheim GmbH and Pfizer Inc. (PFE)’s Spiriva mist inhaler for chronic lung disease may raise the risk of an early death, a review of five studies found. The use of Spiriva administered in mist form was associated with a...

BI / Pfizer - Spiriva: clinical trials, ain't they a bitch!?

Medical / Pharmaceutical : PharmaGossip (6 years ago)

Spiriva, marketed by Pfizer and Boehringer Ingelheim, offered no advantage over an inhaled placebo for moderate-to-very-severe chronic obstructive pulmonary disease, or COPD, researchers reported on Sunday.MoreAlso, remember this. L...

Meta-analysis suggests death risk with BI/Pfizer's Spiriva

Medical / Pharmaceutical : PharmaGossip (4 years ago)

via pharmatimes.com There was some bad news for Boehringer Ingelheim's Spiriva after the mist inhaler formulation, which is co-marketed by Pfizer for chronic obstructive pulmonary disease, was linked with a 52% increase in the risk ...

Breathe Deeply: Spiriva Studies Show Troubling Pattern Of Serious Heart Risks, If You Know Where To Look

Medical / Pharmaceutical : Pharmalot (4 years ago)

Last month, a widely publicized study raised concerns about the safety of the blockbuster Spiriva inhaler that is used to treat chronic obstructive pulmonary isease. The meta-analysis published in the British Medical Journal found t...

Comments



Copyright © 2015 Regator, LLC